Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Imaging in cancer diagnosis and response assessment

Oncology and palliative care · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull

Synopsis

Choose cancer imaging according to the clinical question, sequence diagnosis and staging safely, interpret response and treatment effects, and avoid false precision from incidental or equivocal findings.

  • Imaging answers a defined question: detect a lesion, characterise local anatomy, stage spread, guide biopsy, plan treatment, assess complications or measure response.
  • Ultrasound, CT, MRI, PET-CT, plain radiography and nuclear medicine have complementary strengths; no modality is a universal gold standard for all cancers.
  • Use the tumour-specific first-line staging pathway and image enough anatomy to change management without repeating recent adequate studies.
  • A suspicious imaging finding is not always malignant; infection, inflammation, treatment change and benign lesions can mimic cancer or progression.
  • Compare response with a documented baseline using consistent technique and recognised disease-specific criteria, not impressionistic size language alone.
  • Immunotherapy can cause atypical response and inflammatory appearances; clinical deterioration still requires urgent assessment rather than assuming pseudoprogression.
  • Contrast, radiation, pregnancy, renal function, implanted devices and claustrophobia affect modality selection and preparation.
  • Urgent imaging for cord compression, obstruction, haemorrhage, thrombosis or treatment toxicity is separate from routine restaging intervals.

Key red flags

Imaging emergency

New cord, brain, airway, vascular, bowel or urinary compromise requires same-day targeted imaging and acute specialist action.

Investigation priorities

01
Contrast-enhanced CTFirst step

Stage thoracic, abdominal and pelvic anatomy rapidly and assess many acute complications.

Management branches

SelectMatch modality to the decision

Cancer is suspected or confirmed and imaging is required.

  1. State whether the question is diagnosis, local staging, distant staging, biopsy access, emergency complication or treatment response.
  2. Use the tumour-specific recommended modality and review recent images to avoid duplication, radiation and delay.
  3. Prepare for contrast, pregnancy, renal, allergy, device and access needs, and escalate if the preferred study is unsafe or unavailable.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NHS England cancer programmeNational diagnostic, staging and treatment pathways requiring multidisciplinary imaging review.
  • NICE suspected cancer recommendationsSite- and symptom-specific imaging in initial cancer investigation.
  • Royal College of Pathologists cancer datasetsCorrelation of imaging with histological type, stage and treatment response.
  • NICE shared decision making recommendationsDiscussion of test uncertainty, burdens and consequences for treatment choices.
  • iRECIST immune-response criteriaResearch-consensus framework for unconfirmed progression and confirmatory imaging during immunotherapy.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom